Edwards Lifesciences Corporation provided earnings guidance for the fourth quarter of 2022. For the quarter, the company expects year-over-year and sequential sales growth in constant currency. The company expects reported sales and adjusted EPS to be similar to the third quarter.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
86.1 USD | -2.31% | -2.00% | +12.92% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.92% | 51.88B | |
+9.55% | 222B | |
+14.41% | 196B | |
+24.02% | 148B | |
+33.92% | 114B | |
+4.18% | 65.69B | |
+3.16% | 50.02B | |
-4.32% | 38.81B | |
-1.99% | 34.59B | |
+23.04% | 31.09B |
- Stock Market
- Equities
- EW Stock
- News Edwards Lifesciences Corporation
- Edwards Lifesciences Corporation Provides Earnings Guidance for the Fourth Quarter of 2022